Navigation For Mobile
  2. >
  3. 2022
  4. >
  5. January

Monthly Archives: January 2022

Green Generic Drug Substances: Increased Upfront Costs Offset by Long-Term Profitability

Posted on January 31, 2022 by

Green initiatives may be slowly gaining some traction across the pharmaceutical industry, but there is still a long way to go. These are some astonishing insights from sciencehistory.org. “On a waste-to-product…

Posted in APIs, EHS, generic, green chemistry | Tagged , , | Comments Off on Green Generic Drug Substances: Increased Upfront Costs Offset by Long-Term Profitability

Exploring Neuland’s Therapeutic Segments: Focus on CNS

Posted on January 14, 2022 by

Drug development is exciting. There’s no getting around it: being a part of an industry which aims to improve human health is a great motivator for waking up and heading…

Posted in APIs, Neuland Labs | Tagged , | Comments Off on Exploring Neuland’s Therapeutic Segments: Focus on CNS

Green Chemistry by Design (GCbD): The Earlier, The Better for Pharmaceutical APIs

Posted on January 3, 2022 by

There’s a growing consensus in the pharmaceutical industry that drug makers should embrace green chemistry. The last decade of pharma manufacturing has seen green chemistry practices shift from aspirational stewardship…

Posted in API synthesis, Chemistry, CMC, Effluent, EHS, energy conservation, energy effciency, green chemistry, Route Design, Route Scouting | Tagged , , | Comments Off on Green Chemistry by Design (GCbD): The Earlier, The Better for Pharmaceutical APIs